| WHO - International Digest Of Health Legislation |
|---|
| Canada. Controlled Drugs and Substances Act: Marihuana Medical Access Regulations. SOR/2001-227. Dated 14 June 2001. (Internet address below) |
| Can.02.015 |
|
These Regulations provide seriously ill patients with access to marihuana while it is being researched as a possible medicine. They have been developed in recognition of a need for a more defined process than the one currently used under Sec. 56 of the Controlled Drugs and Substances Act for these patients. They clearly define the circumstances and the manner in which access to marihuana for medical purposes is to be permitted.
|
|
http://canada.gc.ca/gazette/part2/pdf/g2-13514.pdf |
| Canada. Controlled Drugs and Substances Act: Benzodiazepines and Other Targeted Substances Regulations (1091). SOR/2000-217. Dated 1 June 2000. (Canada Gazette, Part II, Vol. 134, No. 13, pp. 1392-1456) |
| Can.00.031 |
|
These Regulations, which have been made in pursuance of the Controlled Drugs and Substances Act (see IDHL, 1996, 47, 490, Can. 96.19), provide a regulatory framework to ensure Canada's compliance with international control measures. They apply to benzodiazepines, their salts and derivatives, and to other psychotropic substances requiring a similar level of regulatory controls.
|
| Canada. Controlled Drugs and Substances Act: Industrial Hemp Regulations. SOR/98- 156. Dated 12 March 1998. (Canada Gazette, Part II, Vol. 132, No. 7, 1 April 1998, pp. 947-979) |
| Can.98.009 |
|
The "Description" rubric of the Regulatory Impact Analysis Statement appended to these Regulations reads as follows: "The Industrial Hemp Regulations (Regulations) will permit the legal production and processing of hemp for commercial purposes while providing compliance and enforcement mechanisms to prevent diversion of Cannabis to the illicit drug market. Cultivation of hemp is currently permitted for scientific studies only under licenses issued by Health Canada under the Controlled Drugs and Substances Act (CDSA). Hemp refers to varieties of the Cannabis plant that have a low content of delta-9-tetrahydrocannabinol (THC) which are generally cultivated for fibre. Varieties with a high content of THC are referred to as marihuana. The psychoactive ingredient in marihuana is THC. Health Canada considers 0.3% content of THC in the plants as the upper limit for determining which varieties of Cannabis are classified as industrial hemp and are permitted for commercial cultivation. The Regulations define industrial hemp as the plants and plant parts of the Cannabis plant, the leaves and flowering heads of which do not contain more than 0.3% THC. It includes the derivatives of the plant and plant parts such as the oil derived from hemp seeds. The Regulations define seed as 'any part of an industrial hemp plant that is represented, sold or used to grow a plant (semence)'. Industrial hemp does not include non-viable Cannabis seed, other than its derivatives, or mature Cannabis stalks. Leaves, flowers, seeds or branches, or fibre derived from those stalks are included."
|
| Canada. Controlled Drugs and Substances Act: Precursor Control Regulations. SOR/2002-359. Dated 24 September 2002. (Internet address below) |
| Can.02.045 |
|
These Regulations provide a regulatory framework to enable Canada to fulfil its international obligations with respect to the monitoring and control of precursors and other chemicals used in the production of illicit drugs. They include the following Parts: I. Class A precursors (Secs. 2-54); II. Class B precursors (Secs. 55-82); and 3. General provisions (Secs. 83-93).
|
|
http://canada.gc.ca/gazette/part2/pdf/g2-13621.pdf |
| Canada. Controlled Drugs and Substances Act: Order amending Schedules II to V to the Controlled Drugs and Substances Act. SOR/2003-32. Dated 30 January 2003. (Internet address below) |
| Can.03.016 |
|
These Regulations provide for: the control of 11 new substances under the Controlled Drugs and Substances Act, the Narcotic Control Regulations, or Part G or J of the Food and Drug Regulations, in accordance with the United Nations Convention on Psychotropic Substances, 1971; and the explicit listing of three substances already included under general headings within the schedules to the Act and its related regulations.
|
|
http://canadagazette.gc.ca/partII/2003/20030212/pdf/g2-13704.pdf |
| Canada. Food and Drugs Act: Regulations amending the Food and Drug Regulations (Zolpiden). SOR/2003-36. Dated 30 January 2003. (Internet address below) |
| Can.03.017 |
|
The main purpose of these amendments is to add the drug zolpidem to the list of substances controlled under the Controlled Drugs and Substances Act and the Benzodiazepines and Other Targeted Substances Regulations (see IDHL, 2000, 51, Can. 00.031), thus bringing the scheduling of zolpidem in Canada in line with the requirements of the United Nations Convention on Psychotropic Substances, 1971.
|
|
http://canadagazette.gc.ca/partII/2003/20030212/pdf/g2-13704.pdf |
| Canada. Controlled Drugs and Substances Act: Regulations amending the Narcotics Control Regulations. SOR/2003-134. Dated 4 April 2003. (Internet address below) |
| Can.03.023 |
|
Amendments concern, inter alia: the clarification of the circumstances under which the Minister of Health can share information with provincial licensing authorities of pharmacy, medicine, dentistry, and veterinary medicine; clearer stipulation of the circumstances under which the Minister must issue a notice and where the Minister has discretion; clearer identification of who must receive notices; and an explicit statement of the measures that the Minister must take prior to the issuance of a notice.
|
|
http://canadagazette.gc.ca/partII/2003/20030423/pdf/g2-13709.pdf |
| Canada. Controlled Drugs and Substances Act: Regulations amending the Marihuana Medical Access Regulations. SOR/2003-387. Dated 3 December 2003. (Internet address below) |
| Can.04.004 |
|
This amendment to the principal Regulations (see IDHL, 2002, 53, Can. 02.015) concerns, inter alia, the implementation of an alternative mechanism to provide for reasonable access to a legal supply of marihuana for medical purposes.
|
|
http://canadagazette.gc.ca/partII/2003/20031217/pdf/g213726.pdf |
| Canada. Controlled Drugs and Substances Act: Order amending Schedule III to the Controlled Drugs and Substances Act. SOR/2003-412. Dated 11 December 2003. (Internet address below) |
| Can.04.007 |
|
Amineptine is added to Schedule III to the Controlled Drugs and Substances Act and to Part I of Part G of the Food and Drug Regulations to meet the requirements of the United Nations Convention on Psychotropic Substances 1971.
|
|
http://canadagazette.gc.ca/partII/2003/20031231/pdf/g2-13727.pdf |
| Canada. Controlled Drugs and Substances Act: Regulations amending the Narcotic Control Regulations and other related Regulations. SOR/2004-237. Dated 26 October 2004. (Internet address below) |
| Can.05.003 |
|
These Regulations, which amend, inter alia, the Narcotic Control Regulations, concern the application for, and issuance of, dealer's licences.
|
|
http://canadagazette.gc.ca/partII/2004/20041117/pdf/g2-13823.pdf |
| Canada. Controlled Drugs and Substances Act: Regulations amending the Food and Drug Regulations. SOR/2004-238. Dated 26 October 2004. (Internet address below) |
| Can.05.004 |
|
These Regulations, which amend Parts G (i.e. controlled drugs) and J (i.e. restricted drugs) of the Food and Drug Regulations, concern the application for, and issuance of, dealer's licences.
|
|
http://canadagazette.gc.ca/partII/2004/20041117/pdf/g2-13823.pdf |
| Canada. Controlled Drugs and Substances Act: Regulations amending the Marihuana Medical Access Regulations. SOR/2005-177. Dated 7 June 2005. (Internet address below) |
| Can.05.049 |
|
The principal Regulations (see IDHL, 2002, 53, Can. 02.015) are amended in order to streamline the regulatory requirements and processes associated with applying for an authorization to possess marihuana for medical purposes. In addition, Health Canada is explicitly authorized to communicate limited information concerning authorizations to possess and licences to produce marihuana for medical purposes to police under prescribed circumstances. Limited authority is also provided for pharmacists to supply marihuana to authorized persons to allow for the conduct of a pilot project to assess the feasibility of distributing marihuana for medical purposes through the conventional pharmacy-based drug distribution system.
|
|
http://canadagazette.gc.ca/partII/2005/20050629/pdf/g2-13913.pdf |
| Canada. Controlled Drugs and Substances Act: Order amending Schedules I and III to the Controlled Drugs and Substances Act (Methamphetamine). SOR/2005-235. Dated 10 August 2005. (Internet address below) |
| Can.05.056 |
|
Methamphetamine is transferred from Schedule III to the Act (see IDHL, 1996, 47, 490, Can. 96.19) to Schedule I.
|
|
http://canadagazette.gc.ca/partII/2005/20050824/pdf/g2-13917.pdf |
| Canada. Food and Drugs Act: Regulations amending the Food and Drug Regulations (ketamine). SOR/2005-270. Dated 31 August 2005. (Internet address below) |
| Can.05.061 |
|
Ketamine is removed from Schedule F to the Food and Drug Regulations and listed under Schedule I to the Controlled Drugs and Substances Act and the Schedule to the Narcotic Control Regulations, the purpose of this action being to enhance public health and safety by reducing the availability of this drug on the illicit market.
|
|
http://canadagazette.gc.ca/partII/2005/20050921/pdf/g2-13919.pdf |
| Canada. Order amending Schedule I to the Controlled Drugs and Substances Act. SOR/2005-271. Dated 31 August 2005. (Internet address below) |
| Can.05.062 |
|
This amendment concerns the inclusion in the Schedule of phencyclidine, its salts, derivatives and analogues and salts of derivatives and analogues, including ketamine.
|
| Notes : See also IDHL, 2005, 56, Can. 05.061. |
|
http://canadagazette.gc.ca/partII/2005/20050921/pdf/g2-13919.pdf |
| Canada. Controlled Drugs and Substances Act: Order amending Schedule I to the Controlled Drugs and Substances Act. SOR/2005-337. Dated 15 November 2005. (Internet address below) |
| Can.06.006 |
|
This amendment clarifies the listing of methamphetamine in Schedule I to the Act, following the amendment introduced by the Order of 10 August 2005 (see IDHL, 2005, 56, Can. 05.056), by explicitly listing its salts. In addition, the derivatives, isomers, analogues, and salts of derivatives, isomers and analogues are included to maintain consistency with methamphetamine's previous treatment under Schedule III.
|
|
http://canadagazette.gc.ca/partII/2005/20051130/pdf/g2-13924.pdf |
| Canada. Controlled Drugs and Substances Act: Order amending Schedule VI to the Controlled Drugs and Substances Act. SOR/2005-364. Dated 21 November 2005. (Internet address below) |
| Can.06.010 |
|
This Order amends Schedule VI to the Act (see IDHL, 1996, 47, 490, Can. 96.19) and the Precursor Control Regulations (see ibid., 2002, 53, Can. 02.045) to strengthen the regulatory framework and minimize any negative impact of the Regulations on legitimate trade in precursors. The following are added to the Schedule: gamma butyrolactone; 1,4-butanediol; red phosphorous; white phosphorous; hypophosphorous acid; and hydriodic acid.
|
|
http://canadagazette.gc.ca/partII/2005/20051214/pdf/g2-13925.pdf |
| WHO - International Digest Of Health Legislation |
|---|